View PDF VersionPrevious ArticleNext Article

Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence
DOI: 10.1039/C5CC90543E (Correction) Chem. Commun., 2015, 51, 17775-17776

Correction: Acid-labile boronate-bridged dextran–bortezomib conjugate with up-regulated hypoxic tumor suppression

Weiguo Xu , Jianxun Ding *, Lingyu Li , Chunsheng Xiao , Xiuli Zhuang and Xuesi Chen
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China. E-mail: jxding@ciac.ac.cn; Fax: +86 431 85262116; Tel: +86 431 85262116

Received 20th November 2015 , Accepted 20th November 2015

First published on 25th November 2015

Abstract

Correction for ‘Acid-labile boronate-bridged dextran–bortezomib conjugate with up-regulated hypoxic tumor suppression’ by Weiguo Xu et al., Chem. Commun., 2015, 51, 6812–6815.

The annotation in Fig. 3A was incorrect, and the unit of the half-maximal inhibitory concentration (IC50) in Fig. 3B was wrong. The correct version of Fig. 3 is shown below.
image file: c5cc90543e-f1.tif
Fig. 3 In vitro cytotoxicities (A) and IC50s (B) of Dex–BTZ and BTZ after incubation for 48 h toward HepG2 cells. The data were presented as mean ± standard deviation (n = 3, *p < 0.05, #p < 0.001).

In addition, the unit for the IC50 values stated in lines 5 and 7 of the right column of page 3 is incorrectly displayed as “nM”. The correct unit is “μM”.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

This journal is © The Royal Society of Chemistry 2015